Anti-malignin Ab (AMA) is an IgM that is spontaneously produced by the host against the oncoprotein malignin when neoplastic transformation occurs; because AMAs are IgM molecules, they are an indicator of 'early' transformation that is useful for the early detection of cancer. This evidence concerns the gene CD40LG and cancer.